Anastomotic Leak Re-exploration
44960
-
44620— Closure of enterostomy (if ostomy created at re-exploration) -
49000— Exploratory laparotomy
Anastomotic leak — status post [index procedure] on [date] / [clinical presentation: fever / tachycardia / peritonitis / drain output consistent with enteric content / CT-confirmed leak]
Confirmed anastomotic [leak / dehiscence / blow-out] at [location] — [contained / free / with peritonitis]
Re-exploration, anastomotic [takedown / repair / washout], [diverting ileostomy / end colostomy / ostomy creation], drainage
[Attending name], MD/DO
[Resident/PA name]
General endotracheal
The patient is a [age]-year-old [male/female] who underwent [index procedure] on [date] and has now presented on post-operative day [X] with [clinical signs: fever / peritonitis / drain output / CT findings] consistent with anastomotic leak. After appropriate resuscitation and administration of broad-spectrum antibiotics [antibiotics], the decision was made to proceed with operative re-exploration. The risks and benefits were discussed with the patient [or surrogate] and consent was obtained.
On re-entry, [feculent / bilious / purulent / serous] contamination was present in [the pelvis / right lower quadrant / diffusely throughout the abdomen]. The index anastomosis at [location] demonstrated [a [X] mm defect / complete dehiscence / ischemic anastomosis / staple line disruption]. The proximal bowel was [viable / ischemic / dilated]. The distal limb was [viable / compromised]. The mesentery was [intact / ischemic]. The degree of peritoneal contamination was [localized / diffuse / feculent].
The patient was brought to the operating room and placed supine. General endotracheal anesthesia was induced. A surgical timeout was performed. The prior midline incision was reopened sharply. Dense adhesions were encountered and carefully taken down, protecting all bowel segments. Intraoperative cultures were obtained from the peritoneal fluid.
The anastomosis was identified at [location]. [Describe findings: partial defect / complete breakdown / ischemic segment]. Given [the extent of contamination / anastomotic ischemia / inability to safely re-anastomose / hemodynamic instability], the decision was made to [take down the anastomosis / divert without takedown].
[Anastomotic takedown:] The anastomosis was resected using a [GIA / TA] stapler with adequate margins on both sides. The bowel ends were inspected and confirmed viable. Given [feculent peritonitis / patient instability / unfavorable local conditions], primary re-anastomosis was deferred. The proximal end was brought out as a [loop ileostomy / end ileostomy / end colostomy] through a separate trephine incision in the [right / left] lower quadrant and matured in the standard fashion. The distal end was [closed as a Hartmann's pouch / brought out as a mucous fistula].
[If primary repair attempted:] The defect was repaired primarily with [2-0 PDS / 3-0 Vicryl] interrupted full-thickness sutures reinforced with a second layer of [Lambert seromuscular] sutures. A diverting [loop ileostomy] was created proximally.
The abdomen was copiously irrigated with [X] liters of warm normal saline until clear return. [Number and location] Jackson-Pratt drains were placed in the [pelvis / right and left paracolic gutters]. The fascia was closed with [#1 PDS] suture. The skin was [left open / closed] given the degree of contamination.
None beyond the indication for re-exploration
Peritoneal cultures — aerobic and anaerobic; [Resected bowel segment to pathology]
[X] mL
[Two] Jackson-Pratt drains — [right pelvis / left pelvis / paracolic gutter]; [ostomy created as described]
The patient remained intubated and was transferred to the surgical ICU in guarded condition. Broad-spectrum antibiotics, vasopressor support, and ICU-level care were continued post-operatively.
Epic SmartPhrase Version
PREOPERATIVE DIAGNOSIS: Anastomotic leak — s/p *** on ***, POD ***
POSTOPERATIVE DIAGNOSIS: *** anastomotic *** at ***
PROCEDURE PERFORMED: Re-exploration, ***, diversion/drainage
ATTENDING SURGEON: ***, MD/DO
FIRST ASSISTANT: ***
ANESTHESIA: General endotracheal
INDICATIONS: The patient is a .PTAGE-year-old .PTSEX s/p *** presenting on POD *** with *** consistent with anastomotic leak. Resuscitated, broad-spectrum abx given. Consent obtained from ***.
FINDINGS: *** contamination on re-entry. Anastomosis at *** with ***. Bowel viability: ***. Contamination: ***.
DESCRIPTION OF PROCEDURE:
Patient supine. General anesthesia. Timeout. Prior incision reopened. Adhesiolysis performed carefully. Cultures obtained from peritoneal fluid.
Anastomosis identified — ***. Decision to [takedown/repair/divert] given ***. [Anastomosis taken down with GIA stapler / Defect repaired primarily with ***]. [Proximal end matured as *** ostomy in *** LQ. Distal end: ***.]
Abdomen irrigated with *** L NS until clear. *** JP drains placed. Fascia closed with #1 PDS. Skin: ***.
EBL: ***
SPECIMENS: Peritoneal cultures; ***
COMPLICATIONS: None beyond indication
DRAINS: *** JP drains; *** ostomy
DISPOSITION: Patient transferred to SICU intubated in guarded condition.
Signed: .ME, .MYDEGREE
.TODAYVariants
Contained Leak — Washout and Drainage Only
The anastomotic leak was contained with a well-formed abscess cavity adjacent to the anastomosis. The anastomosis was intact elsewhere with only a small [pinhole / 3 mm] defect. Given the [contained nature / hemodynamic stability / viable bowel], the decision was made to irrigate, drain, and create a diverting loop ileostomy without anastomotic takedown. The abscess cavity was evacuated and irrigated. A drain was placed adjacent to the anastomosis. A proximal diverting loop ileostomy was matured in the right lower quadrant. The anastomosis is expected to heal with diversion and drainage.
Ischemic Anastomosis
The anastomosis demonstrated [dusky / ischemic / necrotic] bowel with [poor / absent] marginal vessel bleeding. The decision was made to take down the anastomosis with wide resection back to clearly viable bowel. Bowel viability was confirmed by [pink color / active marginal bleeding / Doppler signal]. Given the extent of bowel resection, primary re-anastomosis was deferred in favor of [ostomy creation / damage control with planned re-anastomosis].
Charting Tips
- Document the specific anastomotic defect size and degree of contamination. These drive treatment decisions (contained vs. free leak, repair vs. takedown) and must be explicitly stated. 'Anastomotic leak' without characterization is not adequate operative documentation.
- Document the rationale for the operative strategy chosen (takedown vs. repair vs. diversion alone). This is the most consequential decision of the operation and should be clearly justified in the note with reference to bowel viability, contamination grade, and patient hemodynamics.
- Document cultures taken intraoperatively and post-operative antibiotic plan. Anastomotic leak with peritonitis requires source control + targeted antibiotic therapy; the culture results will guide de-escalation and duration. Note the plan in the operative note.
Billing Tips
- Bill 49002 for reopening of a recent laparotomy wound (17.19 wRVU, 90-day global). Use when returning to the OR to reopen a previously closed abdomen for anastomotic leak, bleeding, or other complication.
- If anastomotic repair is performed, additionally bill 44602 (suture of small intestine, 24.10 wRVU) or 44604 (suture of large intestine, 17.71 wRVU) for the primary repair with modifier -51. Document each separately in the operative note.
- If performed within the global period of the original operation, append modifier -78 (unplanned return to OR for related complication). This reduces payment to the intraoperative component only but is required for accurate coding.
- If a diverting ostomy is created during reexploration, bill 44310 (ileostomy, 17.15 wRVU) or 44320 (colostomy, 19.41 wRVU) with modifier -51. Document that the ostomy was a separate, distinct part of the procedure.
- Document the clinical indication explicitly ('anastomotic leak confirmed by CT' or 'feculent peritoneal contamination encountered'). This is essential for medical necessity review, especially when returning within a global period.